Urinary excretion of orotic acid was measured in controls and in subjects homozygous and heterozygous for lysinuric protein intolerance under various conditions of amino nitrogen intake. In all situations, the controls excreted less than 28 pg/kg/hr. Only one of the two heterozygotes studied differed from tbe controls. The orotic aciduria of homozygotes was normal in fasting but increased on a self-chosen low-protein diet (log mean, 80; range, 8 to 588 pg/kg/hr in 24-hr urine), after cow's milk protein, 0.5 g/ kg (76% 251 to 1747 pg/kg/hr in 4 to Chr urine), oral ammonium lactate, 2.5 mmoles/kg (95; 15 to 1127 pg/kg/hr in 1.5-hr urine), and IV alanine, 6.6 mmoles/kg (51% 47 to 1831 pg/kg/hr in Chr urine).
Summary
Urinary excretion of orotic acid was measured in controls and in subjects homozygous and heterozygous for lysinuric protein intolerance under various conditions of amino nitrogen intake. In all situations, the controls excreted less than 28 pg/kg/hr. Only one of the two heterozygotes studied differed from tbe controls. The orotic aciduria of homozygotes was normal in fasting but increased on a self-chosen low-protein diet (log mean, 80; range, 8 to 588 pg/kg/hr in 24-hr urine), after cow's milk protein, 0.5 g/ kg (76% 251 to 1747 pg/kg/hr in 4 to Chr urine), oral ammonium lactate, 2.5 mmoles/kg (95; 15 to 1127 pg/kg/hr in 1.5-hr urine), and IV alanine, 6.6 mmoles/kg (51% 47 to 1831 pg/kg/hr in Chr urine).
Giving ornithine or citrulline IV with the infusion of alanine prevented the increase in orotic acid excretion. Given orally, citrulline was more efficient than ornithine or arginine. To prevent the hyperammonemic and orotic aciduric responses with ornithine, its plasma concentrations needed to be higher than normal.
Orotic aciduria is a reliable indicator of the function of the urea cycle in lysinuric protein intolerance and facilitates monitoring of the treatment of this disease.
Speculation
The parallel changes in urinary orotic acid and blood ammonia concentrations in lysinuric protein intolerance suggest a close link between the urea cycle and the pyrimidine pathway, probably via carbamyl phosphate and asparate. Follow-up of orotic aciduria is a simple and presumably accurate method for monitoring the home treatment of disorders of the urea cycle.
Patients with enzyme defects of the urea cycle show increased urinary excretion of orotic acid, an intermediate in the biosynthesis of pyrimidines (22) . Orotic aciduria after a protein load reveals hyterozygosity for ornithine transcarbamylase (EC 2.1.3.3) deficiency (6, 8). In experimental animals, excretion rises after ammonium loads (12, 28) and on diets deficient in arginine (14, 15).
Lysinuric protein intolerance (LPI) is an inherited defect of diamino acid transport in the intestine (20) . kidney, and liver (26) . In the affected patients, concentrations of the diamino acid intermediates of the urea cycle, ornithine and arginine, are low in plasma and presumably also in liver cells, which are the site of the cycle. Therefore, urea formation is impaired, and amino nitrogen loads lead to hyperammonemia. Oral ornithine and arginine supplements partly prevent the hyperammonemia (9, 21, 26) . Without such treatment, the patients excrete increased amounts of orotic acid into the urine (3, 21) .
I undertook the present work to prove the hypothesis that orotic aciduria is more sensitive and practical than ammonemia as indicator of urea cycle failure in LPI. For this purpose, the urinary excretion of orotic acid was measured in controls and homozygotes for LPI in basal state and in such standard amino nitrogen loading situations as have previously been characterized for hyperammonemic response in the homozygotes. These were a cow's milk feeding and an IV alanine load. As the hypothesis proved to be true, I proceeded to studying with this new sensitive indicator: (1) the comparative value of oral supplements of citrulline, arginine, and ornithine in normalization of ammonia removal, (2) the plasma ornithine level necessary for this normalization, using repeated oral ammonia loads with IV infusion of ornithine at stepwise increasing rate, and (3) the heterozygous state for LPI.
MATERIALS A N D METHODS

SUBJECTS
Twenty-four homozygotes for LPI (one infant, 14 prepubertal children, one adolescent, eight young adults; 17 females) participated in this study. Fifteen of them have been described earlier (26) . The others similarly had the clinical picture typical of LPI, the diaminoaciduria and the hyperammonernic response to an IV alanine load (26) .
Twenty-four-hr urine specimens were collected from 10 homozygotes during a self-chosen, low-protein diet without amino acid supplementation, 27 healthy obligate heterozygotes (parents of the homozygotes; 14 females), and 90 controls (healthy young adults and hospitalized children of all ages, with normal intake of urea cycle intermediates, not receiving cytostatic treatment and without evidence of urea cycle dysfunction or disorders of pyrimidine or purine metabolism; 3 1 females) on a free or hospital diet.
Twenty homozygotes, two heterozygotes, and nine controls (healthy adults or children first suspected of having impaired urea production, but then found to show normal elevations of serum urea concentrations without hyperammonemia after the IV alanine load) received one or more IV or oral loads each (see "Experiments").
All subjects and/or their guardians had given informed consent to these studies.
EXPERIMENTS
The following loads were given after a 10-hr fast and after a period of at least 24 hr without amino acid supplementation (19) . Only water was allowed during the tests.
L-Alanine, 6.6 mmoles/kg, was given as a constant 90-min infusion of 5% (w/v) solution (9) . On another day, the infusion was repeated with L-citrulline or L-ornithine-HC1, I. 1 mmoles/kg. Urine was collected for 6-hr periods, once before and for 1 to 3 periods after the start of the infusion. Blood ammonia was measured at 0, 120, 180, and 270 min.
As an oral protein load, cow's milk was given to provide 0.5 g of protein per kg. The load was repeated together with 2 or 4 tablets of citrulline (0.414 g each), arginine-HCI (0.5 g), or ornithine-HC1 (0.5 g) on different days. Urine was collected for three subsequent 2-hr periods.
Ammonium lactate, 2.5 mmoles/kg, was given orally as a 1.25 M solution in orange juice. Five percent mannitol with 20 mEq/ liter of NaCl and 10 mEq/liter of KC1 was infused at 12 ml/kg/ hr IV to ensure diuresis. Blood ammonia was measured at 0, 45, 60, 75, and 90 min. Urine was collected for 90 rnin. To raise the plasma ornithine level, infusion of the same solution was then continued with ornithine-HCI added in concentrations increased stepwise at 2.5-hr intervals to 1.5, 3.0,4.5, and 6.0 mM. Each step was preceded by a priming dose of 5% ornithine-HCI IV, equal to 7Wo of the amount of ornithine to be given in the next 60 min. The ammonium lactate load was repeated 60 min after each step. Blood for amino acid analysis was drawn before and 60 rnin after each ammonium load. The mean of the two ornithine concentrations was taken as a steady-state concentration. Two patients (Fig.  2 , patients I and 2) were given 5% glucose instead of mannitol to provide energy during the long experiment. Their results did not differ from those for the other patients.
ANALYTICAL
Blood ammonia was measured with an ammonia-specific electrode (Orion Research Inc., Cambridge, MA) within 30 rnin of drawing the sample (18) . The concentrations of amino acids were determined with an automatic amino acid analyzer (Beckman Unichrom or Beckman 121 M with citrate and lithium buffers, respectively). Urinary orotic acid was analyzed by a modified colorimetric method (1, 6) and creatinine by a modified Jaffe reaction (2). The peak blood ammonia level appeared between 60 and 75 rnin after the ammonium lactate load. The mean of the 60-and 75-min values less the basal value was taken as an estimate of the maximal increment caused by this load.
MATERIALS
Amino acids were obtained from Tanabe Seiyako Co. Ltd., Osaka or Ajinomoto Co. Inc., Tokyo, Japan, and manufactured as tablets and 5% solutions by the Pharmaceutical Plant Leiras, Turku, Finland. Commercial solutions of pure mannitol and glucose were used. Ammonium lactate was obtained as a 60% solution (w/v) from BDH Chemicals, Ltd., Poole, England.
RESULTS
Most untreated homozygotes had clear orotic aciduria (Table  1) . The amount excreted varied greatly, roughly reflecting the protein content of the diet. In the heterozygotes orotic acid excretion was within the range of the controls.
IV ALANINE LOAD (TABLE 2)
During the fast before the load, orotic acid excretion was always minimal. The alanine infusion provoked massive orotic aciduria in all homozygotes, but in none of the controls. The controls had no rise in blood ammonia (9) . One of the heterozygotes was nauseated and drowsy at the end of the alanine infusion, her blood ammonia having risen from 55 (0 min) to 128 pmoles/liter (120 min). Her orotic acid excretion was also clearly increased (1 13 pg/ kg/hr). The other heterozygote tested responded like the controls.
The orotic aciduria of the homozygotes was most marked during the first 6 hr after the load; in some of them it continued for 12 to 18 hr. Blood ammonia normalizes much earlier, usually within 4.5 hr (9) .
The amount of nitrogen excreted by the homozygotes as orotic acid within 12 hr after the load, calculated as a fraction of the alanine nitrogen load, was on the average 0.7% and maximally 4.5%.
The hyperammonemia induced by the alanine load in homozygotes is prevented by giving ornithine IV (24) . After such an alanine plus ornithine load, orotic acid excretion was within the same range in the homozygotes as in the controls after the alanine load. Similarly, hyperammonemia and orotic aciduria could be prevented by giving citrulline IV.
ORAL PROTEIN LOAD (FIG. I )
In the homozygotes, after the intake of cow's milk protein, 0.5 g/kg, no hyperammonemia was detected. However, their orotic Table 1 ' The values are means (on log scale) and ranges. " Numbers in parentheses, numbers of determinations. Two patients had orotic aciduria even after the higher citrulline supplement (asterisks). This response normalized in both patients, when the load was repeated with the same citrulline supplement given twice, at times 0 and 4 hr (a, outside the columns). Logarithmic scale on ordinate.
acid excretion increased, with maximum values 4 to 6 hr after the load (up to 437 times over that during fasting). Gitrulline, given as an oral supplement at 0.12 mmoles/kg, only partially prevented this rise. After a double dose, their orotic acid excretion remained normal for 4 hr but then increased during the next 2 hr in two of the five homozygotes. This late orotic aciduria was abolished by repeating the citrulline dose at 4 hr. In all but one patient, the higher oral doses of arginine and ornithine failed to prevent the orotic aciduria.
Citrulline thus seems to be at least as effective as arginine and ornithine in improving protein tolerance in the homozygotes. The doses have to be sufficiently large. Appparently, 0.5 rnmoles of citrulline per g of ingested protein will prevent the orotic aciduria. The protection afforded by citrulline seems to be rapid, but lasts for only 4 hr. This may be important in the treatment of acute hyperammonemia.
ORAL AMMONIUM LACTATE LOAD
Ammonium lactate load was first given to 15 homozygotes and eight controls. The mean blood ammonia levels were at 0, 45. 60, 75, and 90 min in the homoozygotes 86, 117, 141, 155, and 114 pM and in the controls 40, 47, and 58 pM (90-min value not measured), respectively. The 90-min urinary orotic acid excretion, measured in 10 homozygotes and in five controls, was (log mean; range) 109; 15 to 1127 pg/kg/hr, and 6; 1 to 20 pg/kg/hr, respectively. When the load was then repeated in five homozygotes at elevated plasma ornithine concentrations, the hyperammonemic and orotic aciduric responses decreased (Fig. 2) . However, the responses normalized fully only at supranormal ornithine concentrations. The hyperammonemia was first abolished, and the orotic aciduria only at still higher ornithine concentrations.
PLASMA ORNlTHlNE (pmol/l) Fig. 2 . The effect of plasma ornithine wncentration in homozygotes for LPI on the hyperammonemic and orotic aciduric response to ammonium lactate load. Ornithine was infused in stepwise increasing wncentrations, each increase being preceded by a priming dose. After an equilibration period, an ammonium lactate load was given orally during each ornithine concentration (for details, see "Materials and Methods").
To allow comparison of the two responses, the patients have been identified with numbers. Broken lines, upper limits of the responses in the controls. The normal rage of plasma ornithine wncentration (26 to 75 pmol/liter in our laboratory; n = 17) is shaded on the horizontal axis.
DISCUSSION
All homozygotes for LPI had orotic aciduria after amino nitrogen and ammonia loads. The amounts excreted showed a clear correlation with the degree of hyperammonemia (Fig. 2) . The orotic aciduria thus seems to reflect a decreased capacity of the urea cycle to detoxify ammonia. The enzymes of the pyrimidine pathway have not been studied in LPI, but a defect or inhibition of them is unlikely to be the cause of the orotic aciduria. Orotic aciduria is associated with the hyperammonemic state in all enzyme defects of the urea cycle but not in deficiency of carbamyl phosphate (CP) synthetase I (22) . The hyperammonemia of LPI is also believed to result from hypofunction of the urea cycle due to the decreased availability of diamino acid intermediates of the cycle (26) .
The orotic aciduria in hyperammonemia is most readily explained as follows (Fig. 3) . When the mitochondrial synthesis of CP from ammonia is normal but its further metabolism is blocked, CP will accumulate in the mitochondria. Some of it will leak into the cytoplasm (16, 29) . Cytoplasmic CP and aspartate are the substrates of the orotic acid-pyrimidine pathway. Aspartate, which transfers the second ammonia moiety in urea synthesis is presumably also present in increased amounts. Accumulation of both Drecursors will cause increased vroduction of orotic acid. In certain karginal situations, this shunt& of CP may prevent the increase in blood ammonia concentration, as is seen in patients with LPI who sometimes had orotic aciduria without apparent hyperammonemia. The mitochondrial synthesis of CP may be regulated by the mitochondrial concentration of arginine (13). Although the hepatocellular arginine concentration is believed to be decreased in LPI (26) . the production of CP is evidently not inhibited. 
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In experimental animals, oral administration of urea cycle intermediates will prevent the induced hyperammonemia; the most effective intermediate is arginine (7) . In patients with LPI, arginine, ornithine, and citrulline IV all prevented hyperammonemia and ornithine and citrulline orotic aciduria. For long-term oral supplementation, the most effective is citrulline, probably because in contrast to arginine and ornithine, it is normally absorbed from the intestine of the patients (20) . To normalize the function of the urea cycle, a supranormal plasma concentration of ornithine was needed in LPI. This may be due to impaired transport of ornithine into the hepatic cells (24, 25) . In patients with hyperornithinemia-hyperammonemia-homocitrullinuria plasma ornithine is constantly elevated (5, 23). The basic defect in this disease has been suggested to lie in the mitochondrial uptake of ornithine. In these patients, supranormal ornithine concentrations do not prevent hyperammonemia. However, feeding of supplementary ornithine decreased hyperammonemia even in these patients (4) .
In contrast to the homozygotes, the heterozygotes for LPI have normal capacity to ammonia removal, according to absence of an increase in blood ammonia after the standard IV alanine load (17) . So far, the only established biochemical feature to distinguish the heterozygotes from controls is a decreased efficiency of intestinal lysine absorption; their plasma lysine levels after an oral lysine load were intermediate between the levels observed in controls and homozygotes (20) . Their intestinal absorption of ornithine and arginine has not been adequately studied. My present finding of normal daily urinary excretion of orotic acid indicates that the heterozygotes have suficient availability of the urea cycle intermediates in the basal state. Only two of them were available for testing with the alanine load. One of the two had a clearly increased response in orotic acid excretion. This suggests that some of the heterozygotes may have a limited reserve to ammonia removal.
Orotic acid seems to be only slightly toxic. It may disturb purine metabolism by depleting the liver of 5-phosphoribosyl-I-pyrophosphate (10, 27) . This is a substrate needed for the synthesis of pyrimidines from orotic acid, and is probably also the rate-limiting factor in purine synthesis. A resulting imbalance of purine and pyrimidine production may be one of the causes of the impaired growth and mental retardation associated with hyperammonemia.
Feeding rats o n a diet with added orotic acid produces fatty liver (30) . Changes in liver morphology are also a constant finding in LPI (26) . However, protein malnutrition and lysine deficiency are more likely reasons for the changes than orotic acid. Orotic acid stones have been found in hereditary orotic aciduria but not in hyperammonemic patients (I I). Presumably, the amounts excreted by them are too small to produce concrements. In LPI and probably in other hyperammonemic diseases, measurement of orotic aciduria offers a valuable parameter of control. It is more sensitive than measurements of blood ammonia in diagnosing the disease and in revealing the effect of oral protein load. It may be that orotic acid production increases more readily than blood ammonia rises. On the other hand, orotic aciduria gives an integrated measure for a period of several hr or even days, in contrast to blood ammonia. Easy collection of urine and the possibility for mailing urine samples from home make orotic aciduria a suitable parameter for following home treatment of patients with hyperammonemia. 
